Cargando…
Synergistic anti-tumor effects of dasatinib and dendritic cell vaccine on metastatic breast cancer in a mouse model
Immunotherapy is currently considered as one of the major anti-tumor modalities, but its efficacy is limited. Dasatinib could improve the expansion and recruitment of cluster of differentiation (CD) 8(+)T cells and natural killer (NK) cells to the tumor microenvironment. The present study aimed to e...
Autores principales: | Song, Ningning, Guo, Hulin, Ren, Jia, Hao, Suhong, Wang, Xinchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920940/ https://www.ncbi.nlm.nih.gov/pubmed/29731862 http://dx.doi.org/10.3892/ol.2018.8188 |
Ejemplares similares
-
Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity
por: Bolf, Eric L., et al.
Publicado: (2023) -
Anti-Programmed Cell Death-1 Antibody and Dasatinib Combination Therapy Exhibits Efficacy in Metastatic Colorectal Cancer Mouse Models
por: Kadota, Hiroki, et al.
Publicado: (2022) -
Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
por: Araujo, John C, et al.
Publicado: (2013) -
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
por: Lowe, Devin B, et al.
Publicado: (2014) -
Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β
por: Bellat, Vanessa, et al.
Publicado: (2020)